-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse London Stock ExchangeISIN GB0009252882-
GlaxosmithklineBörse London Stock ExchangeISIN GB0009252882Symbol GSK
-
GlaxosmithklineBörse Börse FrankfurtISIN GB0009252882 WKN: 940561EURSymbol GS7
-
GlaxosmithklineBörse Börse BerlinEURSymbol GS7A
-
GLAXOSMITHKLINE PLC-SPON ADRBörse Börse FrankfurtEURSymbol GS7A
-
GlaxosmithklineBörse Börse StuttgartEURSymbol GS7A
-
GlaxosmithklineBörse Börse MünchenEURSymbol GS7A
-
GlaxosmithklineBörse Gettex System der Börse MünchenEURSymbol GS7A
-
GLAXOSMITHKLINE PLCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse BerlinEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Quotrix System der Börse DüsseldorfEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse HamburgEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse DüsseldorfEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse MünchenEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse StuttgartEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Gettex System der Börse MünchenEURSymbol GS7
-
GlaxosmithklineBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GS7A
-
GlaxosmithklineBörse Börse HamburgEURSymbol GS7A
-
GlaxosmithklineBörse Quotrix System der Börse DüsseldorfEURSymbol GS7A
-
GlaxosmithklineBörse Börse DüsseldorfEURSymbol GS7A
-
GlaxosmithklineBörse NYSE New York Stock ExchangeISIN GB0009252882 WKN: 940561Symbol GSK
-
GlaxosmithklineBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"USDSymbol GSK.LN
-
GlaxoSmithKline PLC ADRBörse NYSE New York Stock ExchangeISIN US37733W1053 WKN: 940610Symbol GSK
-
INRGLAXOSMITHKLINE PHARMACEUTICALBörse BSE
-
USDGlaxosmithklineBörse Freiverkehr OTC
-
Symbol GS7
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
93.879.525.376 oder 82.199.000.000 oder 81.582.338.640
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
94.066 oder 90.096 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
13.04 oder 18.9
Zahlte zuletzt am 20.05.2021 eine Dividende von 19 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Glaxosmithkline läuft ähnlich wie der DAX (1.29 %) vom 05.07.2021 bis 10.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1478,4 GBp +0,73%
Aktionärsstruktur der GlaxoSmithKline plc
Portrait der Glaxosmithkline Aktie
Das Unternehmen GlaxoSmithKline plc aus Großbritannien beschäftigt 92.081 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Pharma tätig.
Die Glaxosmithkline Aktie hat inklusive der Dividendenausschüttungen seit dem 05.07.2021 eine Gesamtrendite von 0% erwirtschaftet
Das Unternehmen GlaxoSmithKline plc ist in mehr als 78 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe Select Dividend 30 UCITS ETF (DE) gewichtet Glaxosmithkline mit 6,17% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Glaxosmithkline Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen GlaxoSmithKline plc am höchsten gewichtet ist Insgesamt in 78 ETFs enthalten
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
238 News & Informationen zur Glaxosmithkline Aktie
Sanofi and GSK to conduct first global efficacy trial of covid vaccine
While Sanofi has developed the antigen–the main component of the vaccine that contains spike proteins of the coronavirus–GSK is supplying its pandemic adjuvant, which will be used to boost the immune response of the antigen.
Biodefense Market Growth Analysis in Biotechnology Industry | Technavio
/PRNewswire/ — Set to grow by USD 5.41 billion during 2021-2025, Technavio's latest market research report estimates the biodefense market to register a CAGR…
Biodefense Market Growth Analysis in Biotechnology Industry | Technavio
NEW YORK, July 7, 2021 /PRNewswire/ — Set to grow by USD 5.41 billion during 2021-2025, Technavio's latest market research report estimates the b…
Global Anticoagulants Market (2021 to 2026) – by Drug Class, Route of Administration and Geography
DUBLIN, July 7, 2021 /PRNewswire/ — The 'Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impac…
Outlook On The Pulmonary Drugs Global Market To 2026 – Rising Prevalence Of Pulmonary Diseases Is Driving Growth
DUBLIN, July 7, 2021 /PRNewswire/ — The “Global Pulmonary Drugs Market (2021-2026) by Drug Class, Indication, Distribution Channel, Geography, Competitive
Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs
25 Highest Asthma Rates in the US by City
In this article we will take a look at the 25 highest Asthma Rates in the US by City. You can skip our detailed analysis of these cities and the problem…
Why Alector Zoomed 12% Higher Today
The company has yet another fine July trading day thanks to a Citigroup analyst.
10 Psychedelic Startups Investors are Flocking To
In this article, we discuss the 10 psychedelic startups investors are flocking to. If you want to skip our detailed analysis of these startups, go directly…
Here are my best stocks to buy in July
Zaven Boyrazian is looking for the best stocks to buy in July and shares two businesses on his radar that are undergoing growth transformations.
2 ESG-friendly dividend stocks in which I’d invest £1,000
With investors like him looking for income and sustainability, Jonathan Smith runs through two ESG-friendly dividend stocks that tick both boxes.
Worldwide End Stage Renal Disease Industry To 2026 – High Focus On Technology Presents Opportunities
DUBLIN, July 5, 2021 /PRNewswire/ — The “Global End Stage Renal Disease Market (2021-2026) by Disease Type, Treatment Type, End-user, Geography, Competitive
Global Pulmonary Arterial Hypertension Market (2021 to 2026) – by Drug Class, Route of Administration, Distribution Mode and Geography
/PRNewswire/ — The “Global Pulmonary Arterial Hypertension Market (2021-2026) by Drug Class, Route of Administration, Distribution Mode, Geography,…
How large companies can manufacture profits to permit dividend payments
Richard Murphy on tax, accounting and political economy
European business leaders want a stronger hand with China, not decoupling
Executives from top European companies say EU calls for ‘strategic autonomy’ risk protectionism
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the ye…
Why Alector Blasted Higher Today
It's not every day that a small biotech announces a major collaboration deal with a deep-pocketed pharmaceutical giant.
Don't Miss What Sent These 2 Little-Known Nasdaq Newsmakers Soaring
One of these companies is making big waves.
LATE BRIEFING – Unternehmen und Märkte -2-
LATE BRIEFING – Unternehmen und Märkte -2- | Nachricht | finanzen.net
Alector Shares Up After GlaxoSmithKline Collaboration
By Stephen Nakrosis
Alector Inc. shares touched a 52-week high Friday after the biotechnology company said it would collaborate with GlaxoSmithKline PLC to develop and commercialize… | July 2, 2021
Virgin Galactic Soars in Premarket; Didi, Krispy Kreme Fall By Investing.com
Virgin Galactic Soars in Premarket; Didi, Krispy Kreme Fall
Carcinogens still vex pharmaceutical industry years after recalls started
Years after millions of blood-pressure pills were recalled for containing potentially cancer-causing chemicals, US regulators are still grappling with curbing contaminants that keep turning up in tainted drugs. A task force of Food and Drug Administration chemists, toxicologists and analytical lab staff have been meeting regularly since 2018 to find…
GlaxoSmithKline : GSK and Alector announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases
For media and investors only
Issued:London, UK
GSK and Alector to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range… | July 2, 2021
Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases
Alector and GSK to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases, including frontotemporal dementia, amyotrophic lateral… | July 2, 2021
GlaxoSmithKline : (the ‘Company' or 'GSK') (Form 6-K)
Issued: 2 July 2021, London UK
Elliott Advisors letter to GSK
The Board of GSK notes the letter issued by Elliott Advisors Limited on 1 July…. | July 2, 2021
Is a Bigger Shake-Up at GlaxoSmithKline on the Way?
An activist investor seems to be pushing for one.
GSK rejects activist Elliott's demands for board and consumer business
GSK's (GSK.L) board on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from its pharma business, a day after strongly worded proposals from the activist investor.
Warum die Curevac-Aktie heute um 10,53 % gefallen ist
Curevac-Aktien sind heute (01.07.2021) nach einer kleinen Erholung um 10,53 % gefallen. Die Gründe und weitere Details erfährst du hier.
EMEA Morning Briefing : Stocks to Rise After S&P -2-
Around 50 Jewish families built trailer-sized homes of concrete blocks and metal-sheet roofs on the hilltop outpost in Evyatar starting in May, sparking daily protests by local Palestinians who…
ADRs Tick Up Thursday; Shares of Alterity Soar 65%
By Micah Maidenberg The S&P/BNY Mellon of American depositary receipts rose 0.3% Thursday to 169.76. The European index closed at 143.48, up 0.5%. The Asian index slipped 1% to 239.06,…
GlaxoSmithKline (GSK) Investor Presentation – Slideshow (NYSE:GSK)
The following slide deck was published by GlaxoSmithKline plc in conjunction with this event.
Activist investor Elliott pushes shake-up at GlaxoSmithKline
Hedge fund calls on drug giant to replace directors and review the future role of its CEO to improve performance
A Trio of Stock Picks for Growth-Oriented Investors
GuruFocus Article or News written by Alberto Abaterusso and the topic is about: These stocks seem to be underestimated by the market and are growing their trailing 12-month net earnings significantly
Antibiotics Market Size Worth USD 64,532 Million by 2025 at 4.8% CAGR – Report by Market Research Future (MRFR)
Antibiotics Market Insights and Industry Analysis by Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), Drug Class…
Global Mobile Medical Apps Market to Reach $16.5 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Micron, CureVac Fall Premarket; Walgreens Rises By Investing.com
Micron, CureVac Fall Premarket; Walgreens Rises
Investor Elliott wants GSK leadership settled before split
Activist investor Elliott said GlaxoSmithKline (GSK.L) should review its leadership and consider a sale of its consumer healthcare business as it confirmed on Thursday that it had taken a significant stake in the British pharmaceuticals group.
GlaxoSmithKline's and Vir's Latest COVID Therapy Results: What Investors Should Know
The sample size was small, but the results were impressive.
FTSE 100 Gains as Retailers, Miners, Oil Stocks Rise
FTSE 100 Gains as Retailers, Miners, Oil Stocks Rise 0813 GMT – The FTSE 100 Index rises 1.2%, or 83 points to 7120 as broad-based gains for retailers, miners and oil stocks offset losses for a…
'Submit safety data first': Govt expert panel says no to Covovax trials on children
The Serum Institute had applied to the DCGI on Monday seeking permission for conducting a trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups, at 10 sites